Your browser is no longer supported. Please, upgrade your browser.
HROW Harrow Health, Inc. daily Stock Chart
Harrow Health, Inc.
Index- P/E- EPS (ttm)-0.95 Insider Own0.40% Shs Outstand25.87M Perf Week3.32%
Market Cap148.28M Forward P/E197.00 EPS next Y0.03 Insider Trans358.61% Shs Float23.78M Perf Month17.96%
Income-24.10M PEG- EPS next Q-0.10 Inst Own40.60% Short Float6.45% Perf Quarter35.24%
Sales50.70M P/S2.92 EPS this Y-99.00% Inst Trans2.96% Short Ratio7.32 Perf Half Y-12.05%
Book/sh0.59 P/B10.02 EPS next Y112.90% ROA-42.70% Target Price10.00 Perf Year-17.11%
Cash/sh0.73 P/C8.10 EPS next 5Y15.00% ROE-94.40% 52W Range3.33 - 7.92 Perf YTD-24.04%
Dividend- P/FCF370.70 EPS past 5Y14.90% ROI-11.50% 52W High-25.38% Beta0.88
Dividend %- Quick Ratio1.60 Sales past 5Y98.50% Gross Margin67.50% 52W Low77.48% ATR0.27
Employees133 Current Ratio2.00 Sales Q/Q-4.10% Oper. Margin-9.60% RSI (14)58.47 Volatility4.66% 4.95%
OptionableYes Debt/Eq0.93 EPS Q/Q-216.80% Profit Margin-47.50% Rel Volume1.55 Prev Close5.87
ShortableYes LT Debt/Eq0.76 EarningsAug 10 AMC Payout- Avg Volume209.44K Price5.91
Recom2.00 SMA205.80% SMA505.44% SMA2006.36% Volume324,785 Change0.68%
Aug-10-20 08:05PM  
Aug-07-20 11:05AM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-27-20 07:30AM  
Jul-24-20 10:24AM  
Jul-13-20 07:30AM  
Jun-30-20 11:57PM  
Jun-29-20 07:30AM  
Jun-24-20 08:30AM  
Jun-18-20 07:30AM  
May-14-20 08:40AM  
May-11-20 06:55PM  
May-05-20 08:52AM  
Apr-27-20 07:30AM  
Mar-24-20 07:30AM  
Mar-17-20 07:30AM  
Mar-13-20 11:15AM  
Mar-12-20 09:29AM  
Mar-09-20 07:30AM  
Mar-06-20 12:30PM  
Mar-03-20 07:30AM  
Feb-27-20 07:30AM  
Feb-03-20 09:24AM  
Jan-27-20 11:34AM  
Dec-16-19 07:35AM  
Dec-12-19 07:40AM  
Dec-10-19 07:40PM  
Nov-13-19 06:55PM  
Nov-06-19 10:30AM  
Oct-30-19 12:44PM  
Oct-28-19 10:47AM  
Oct-24-19 07:30AM  
Oct-23-19 07:30AM  
Oct-08-19 07:35AM  
Sep-20-19 08:15AM  
Sep-18-19 10:35AM  
Sep-17-19 07:43AM  
Aug-27-19 07:30AM  
Aug-19-19 06:24AM  
Aug-15-19 04:22PM  
Aug-14-19 05:35PM  
Aug-07-19 10:30AM  
Aug-02-19 07:30AM  
Jul-31-19 07:30AM  
Jul-25-19 07:30AM  
Jul-10-19 02:57PM  
Jun-25-19 05:46PM  
Jun-19-19 08:25AM  
Jun-18-19 10:51AM  
May-30-19 02:03PM  
May-29-19 07:00AM  
May-10-19 05:14AM  
May-09-19 04:01PM  
May-07-19 07:00AM  
May-02-19 07:00AM  
Apr-30-19 07:00AM  
Apr-29-19 08:55AM  
Mar-15-19 11:15AM  
Mar-13-19 03:48PM  
Mar-12-19 04:01PM  
Mar-04-19 07:00AM  
Feb-28-19 07:00AM  
Feb-13-19 07:00AM  
Feb-07-19 07:00AM  
Feb-05-19 07:00AM  
Jan-15-19 11:57AM  
Harrow Health, Inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the United States. The company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. It also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. Its products portfolio includes topical eye drop drug candidates, including SURF-100 and SURF-200; SURF-300, an oral capsule for treating patients suffering from ocular surface diseases, and DED signs and symptoms; Klarity drops to protect and rehabilitate the ocular surface pathology for patients with DED; MELT-100, a drug that is administered sublingually for conscious sedation during cataract surgery; MAY-66 that is used for the treatment of symptoms associated with Peyronie's disease; MAY-44, a non-estrogen topical analgesic gel; and other drug candidates for rare diseases. In addition, the company engages in the development of MAY-88, an oral anhydrous extend release suspension of pentosan polysulfate sodium for interstitial cystitis. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Opaleye Management Inc.10% OwnerJul 12Buy4.9920,900104,2462,827,100Jul 14 09:45 PM
Opaleye Management Inc.10% OwnerJul 11Buy4.9646,800231,9222,808,100Jul 14 09:45 PM
Opaleye Management Inc.10% OwnerJul 10Buy4.9845,000223,9652,761,300Jul 14 09:45 PM
Opaleye Management Inc.10% OwnerJul 09Buy4.8430,000145,0792,716,300Jul 09 09:30 PM
Opaleye Management Inc.10% OwnerJul 08Buy4.9965,000324,6302,691,300Jul 09 09:30 PM
Opaleye Management Inc.10% OwnerJul 07Buy5.1841,300213,9962,626,300Jul 09 09:30 PM
Opaleye Management Inc.10% OwnerJun 19Buy5.5835,000195,4022,585,000Jun 23 09:45 PM
Opaleye Management Inc.10% OwnerJun 04Buy5.7910,00057,8612,550,000Jun 04 06:06 PM
Opaleye Management Inc.10% OwnerJun 03Buy5.7420,600118,3082,540,000Jun 04 06:06 PM
Opaleye Management Inc.10% OwnerJun 02Buy5.6919,400110,3392,519,400Jun 04 06:06 PM
Opaleye Management Inc.10% OwnerMay 22Buy5.0413,80469,5892,500,000May 22 07:22 PM
Opaleye Management Inc.10% OwnerMay 21Buy4.6610,59649,3382,491,196May 22 07:22 PM
Opaleye Management Inc.10% OwnerMay 20Buy4.491,5006,7392,480,800May 22 07:22 PM
AUSTIN STEPHEN GDirectorMar 16Option Exercise0.0072,218091,987Mar 18 06:59 PM
Kammer Robert JDirectorNov 11Sale4.756,50030,875797,327Nov 13 07:00 PM